Caplin Point Laboratories and its subsidiaries have earmarked investments in Tamil Nadu. Caplin Group of Companies signed a Memorandum of Understanding (MoU) with the Tamil Nadu Government during the Tamil Nadu Global Investors Meet, 2024. This MoU outlines Caplin Group's commitment to invest Rs 700 crore over a period of 5 years in diverse projects. This investment will be made by Caplin Point Laboratories and its subsidiaries - Caplin Steriles and Caplin One Labs.
The MoU specifies that the government will provide necessary infrastructure and regulatory assistance as per applicable laws. This will also enable the availing of standard incentives, subject to eligibility. The investments, spanning Oncology, Active Pharmaceutical Ingredients and R&D facilities, are projected to generate 1,500 employment opportunities (1,000 direct and 500 indirect).
Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1854.15 |
Dr. Reddys Lab | 1350.75 |
Cipla | 1497.80 |
Lupin | 2357.65 |
Zydus Lifesciences | 1001.20 |
View more.. |